NDC 52959-457 - Gabazolamine-0.5
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 52959-457
- Package NDCs from labels
- 52959-457-30
- Manufacturer
- Physician Therapeutics LLC | Sandoz Inc | H.J. Harkins Company, Inc | Targeted Medical Pharma Inc.
- Effective date
- 2011-08-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Gabazolamine-0.5 | Physician Therapeutics LLC | Sandoz Inc | H.J. Harkins Company, Inc | Targeted Medical Pharma Inc. | 2011-08-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 52959-457-30 | Gabazolamine-0.5 | 30 in 1 BOTTLE | TABLET | 30 | 0.5 mg | 8 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Senna-S | SENNOSIDES 8.6MG AND DOCUSATE SODIUM 50MG | Proficient Rx LP | 8678a3ee-0e2c-4c95-ad2e-83aa601f3238 | 2024-10-01 | Warnings | F05Q2T2JA0 |
| Pedia-Lax | DOCUSATE SODIUM | C.B. Fleet Company, Inc. | 0e908bea-ebab-44e7-919c-90002e6f5d42 | 2024-10-01 | Warnings | F05Q2T2JA0 |
| SODIUM PHENYLACETATE AND SODIUM BENZOATE | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Zydus Pharmaceuticals USA Inc. | 204e84a7-5440-4537-9e40-06eb56c415e9 | 2024-09-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Sodium Phenylacetate and sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Navinta LLC | fbc7bfe3-6faa-45a3-befb-9ad7963c0571 | 2024-09-30 | Warnings, Adverse reactions | OJ245FE5EU |
| Natural Vegetable Laxative and Stool Softener | DOCUSATE SODIUM AND SENNOSIDES | BETTER LIVING BRANDS LLC. | f2c562e1-4080-44cb-e053-2a95a90a4222 | 2024-09-25 | Warnings | F05Q2T2JA0 |
| SENNA-S LAXATIVE WITH STOOL SOFTENER | SENNOSIDES | Basic Drugs, Inc. | d32b9956-fc04-8d64-e053-2a95a90a17b3 | 2024-09-14 | Warnings | F05Q2T2JA0 |
| DOCUSATE SODIUM, EXTRA STRENGTH 250 MG | DOCUSATE SODIUM | Advanced Rx LLC | e8be12c5-c591-eadd-e053-2a95a90a431b | 2024-09-13 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM AND SENNOSIDES | H E B | 4fcfb8ff-5b99-4bb3-9a2b-c95f47d74b8b | 2024-09-09 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM AND SENNOSIDES | AmerisourceBergen (Good Neighbor Pharmacy) 46122 | 7e573645-b156-4768-8e69-00998f508073 | 2024-09-06 | Warnings | F05Q2T2JA0 |
| Stool Softener Plus Stimulant Laxative | DOCUSATE SODIUM AND SENNOSIDES | Care One (Retail Business Services, LLC.) | 7f4f7fcb-5202-4184-80ef-b4b6c6460c2f | 2024-09-04 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative Plus Stimulant | DOCUSATE SODIUM AND SENNOSIDES | Dolgencorp, Inc. (DOLLAR GENERAL & REXALL) | 5bdc4291-2565-49be-93f1-84f60f983135 | 2024-09-04 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM AND SENNOSIDES | Best Choice (Valu Merchandisers Company) | 4bcf2ea2-7de2-4b89-b7b4-e132457f8a81 | 2024-09-04 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM AND SENNOSIDES | QUALITY CHOICE (Chain Drug Marketing Association) | 19e10544-81f4-4c2d-8a63-238c562c2f5c | 2024-09-04 | Warnings | F05Q2T2JA0 |
| Stool Softener Laxative | DOCUSATE SODIUM AND SENNOSIDES | United Natural Foods, Inc. dba UNFI | db15be6e-9ac6-4cf9-89f8-14480c89fcd2 | 2024-09-04 | Warnings | F05Q2T2JA0 |
| Alprazolam | ALPRAZOLAM | NuCare Pharmaceuticals,Inc. | f7e63d96-2310-4ab1-e053-6294a90a86fc | 2024-09-03 | Boxed warning, Warnings, Adverse reactions | 197321 YU55MQ3IZY |
| STOOL SOFTENER AND STIMULANT LAXATIVE | DOCUSATE SODIUM AND SENNOSIDES | TARGET CORPORATION | 7cac99da-8d89-0aee-e053-2991aa0a0fd9 | 2024-08-22 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | Padagis Israel Pharmaceuticals Ltd | bce3b245-ec47-4e62-9cad-bb12d0812c18 | 2024-08-15 | Warnings | F05Q2T2JA0 |
| Docusate Sodium | DOCUSATE SODIUM | NuCare Pharmaceuticals,Inc. | 56f7966a-c95e-3ce3-e054-00144ff88e88 | 2024-08-14 | Warnings | F05Q2T2JA0 |
| Sool Softener Laxative | DOCUSATE SODIUM, SENNOSIDES | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | 7104b955-fadd-4ce7-9342-fb28027fc4a9 | 2024-08-12 | Warnings | F05Q2T2JA0 |
| Senna S Orange | DOCUSATE SODIUM SENNOSIDES | Care One (Retail Business Services, LLC.) | 3da76cb2-08c3-475d-9320-69450bbcf8cd | 2024-08-09 | Warnings | F05Q2T2JA0 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.